Bladder cancer

Immunotherapy and antibody-drug conjugates: handling AEs and special populations

Last updated: 06.07.2023

Solve cases and receive feedback

Case 1 - mUCa, grade 2 pneumonitis while on IO

Case 2 - mUCa, platinum- and IO-refractory

Case 3 - mUCa, with systemic lupus

Case 4 - mUCa, IO stopped due to AE

Case 5 - mUCa, with grade 2 neuropathy

Case 6 - mUCa, with brain metastasis

Case 7 - mUCa, grade 3 pneumonitis while on IO

Case 8 - mUCa, with severe diabetes mellitus

Follow a course and earn CME credits

Earn CME credits by running a case series and completing an assessment. Many topics available for various disease areas. And all for free!

Start a course